Potency Assurance Strategy
In this revised draft, FDA gives a substantial facelift to its original 2011 guideline on Potency assays for Cell and Gene Therapies. It...
Potency Assurance Strategy
Critical Thinking
Big Data vs. Big Pharma
Hidden Opportunities
Take it personally
Careful Innovation
Early Adopters
The Rare Disease CMC Crunch
The Documentation Paradox
The 7 Stages of Compliance
Regulatory "Events"
Knowledge Culture
Don’t call me name(s)
Stop Wasting your Knowledge!
Somewhere over the rainbow...
Knowledge, Risk and Benefit
Tech-Knowledgy Transfer
QTPP of a Boiled Egg...
Digital Swimming lessons
ICH guidelines and the tower of Babel
Don't grow up, it's a trap!
Jargonauts
What Machines Need
Early Intervention